Evidence map›Paper›PMID 30787884›Full record

ArticleFrontiers in psychiatry2019

Morning Plasma Melatonin Differences in Autism: Beyond the Impact of Pineal Gland Volume.

Anna Maruani, Guillaume Dumas, Anita Beggiato, Nicolas Traut, Hugo Peyre, Alicia Cohen-Freoua, Frédérique Amsellem, Monique Elmaleh, David Germanaud, Jean-Marie Launay and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Anna MaruaniChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Guillaume DumasHuman Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
Anita BeggiatoChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Nicolas TrautHuman Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
Hugo PeyreChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Alicia Cohen-FreouaChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Frédérique AmsellemChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Monique ElmalehPediatric Radiology Department, Robert Debré Hospital, Paris, France.
David GermanaudDepartment of Pediatric Neurology, Robert Debré Hospital, AP-HP, Paris, France.
Jean-Marie LaunayBiochemistry Department, INSERM U942, Lariboisière Hospital, Assistance Publique-Hopitaux de Paris EA 3621, Paris, France.
Thomas BourgeronHuman Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
Roberto ToroHuman Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
Richard DelormeChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Hôpital Robert-Debré · FRInstitut Pasteur · FRAssistance Publique – Hôpitaux de Paris · FRCEA Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While low plasma melatonin, a neuro-hormone synthesized in the pineal gland, has been frequently associated with autism, our understanding of the mechanisms behind it have remained unclear. In this exploratory study, we hypothesized that low melatonin levels in ASD could be linked to a decrease of the pineal gland volume (PGV). PGV estimates with magnetic resonance imaging (MRI) with a voxel-based volumetric measurement method and early morning plasma melatonin levels were evaluated for 215 participants, including 78 individuals with ASD, 90 unaffected relatives, and 47 controls. We first found that both early morning melatonin level and PGV were lower in patients compared to controls. We secondly built a linear model and observed that plasma melatonin was correlated to the group of the participant, but also to the PGV. To further understand the relationship between PGV and melatonin, we generated a normative model of the PGV relationship with melatonin level based on control participant data. We found an effect of PGV on normalized melatonin levels in ASD. Melatonin deficit appeared however more related to the group of the subject. Thus, melatonin variations in ASD could be mainly driven by melatonin pathway dysregulation.

Indexed as

autism spectrum disorderchildrencircadian rhythmMRIpineal glandsleep

Identifiers

PMID30787884
PMCPMC6372551
OpenAlexW2908878371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.